|Articles|September 18, 2020
Central Laboratory Capabilities for Immuno-Oncology Trials
Author(s)Cerba Research
For immuno-oncology trials, partner with a global central lab that can generate early insights to optimize your protocol and ramp up to commercial scale while preserving budgets and timelines.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New AI Oncology Alliance Highlights Industry Push for Scalable Genomics
2
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
3
What Are the Benefits of Single-Use in CGT Manufacturing?
4
China Approves First Monthly Biologic for COPD
5